STAGE I BLADDER CANCER AJCC V8
Clinical trials for STAGE I BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough bladder cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to the chemotherapy drug gemcitabine can help people with a type of bladder cancer that didn't get better with standard BCG treatment. About 161 adults with non-muscle invasive bladder cancer will receive both d…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Bladder cancer survivors: new study tracks life after treatment
Knowledge-focused OngoingThis study follows 204 people with early to mid-stage bladder cancer to see how their treatment (surgery or radiation) affects their daily life. Participants fill out surveys about physical function, pain, fatigue, mood, and social activities before and after treatment. The goal …
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC